Cargando…

UPLC-MS/MS of Atractylenolide I, Atractylenolide II, Atractylenolide III, and Atractyloside A in Rat Plasma after Oral Administration of Raw and Wheat Bran-Processed Atractylodis Rhizoma

Atractylodis Rhizoma is the dried rhizome of Atractylodes lancea (Thunb.) DC. or Atractylodes chinensis (DC.) Koidz and is often processed by stir-frying with wheat bran to reduce its dryness and increase its spleen tonifying activity. However, the mechanism by which the processing has this effect r...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Shizhao, Qi, Xiaojie, Liu, Yuqiang, Liu, Yuhan, Lv, Xin, Sun, Jianzhi, Cai, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320938/
https://www.ncbi.nlm.nih.gov/pubmed/30544552
http://dx.doi.org/10.3390/molecules23123234
_version_ 1783385323637571584
author Xu, Shizhao
Qi, Xiaojie
Liu, Yuqiang
Liu, Yuhan
Lv, Xin
Sun, Jianzhi
Cai, Qian
author_facet Xu, Shizhao
Qi, Xiaojie
Liu, Yuqiang
Liu, Yuhan
Lv, Xin
Sun, Jianzhi
Cai, Qian
author_sort Xu, Shizhao
collection PubMed
description Atractylodis Rhizoma is the dried rhizome of Atractylodes lancea (Thunb.) DC. or Atractylodes chinensis (DC.) Koidz and is often processed by stir-frying with wheat bran to reduce its dryness and increase its spleen tonifying activity. However, the mechanism by which the processing has this effect remains unknown. To explain the mechanism based on the pharmacokinetics of the active compounds, a rapid, sensitive ultra-performance liquid chromatography-tandem mass spectrometry method was developed to analyze atractylenolides I, II, and III, and atractyloside A simultaneously in rat plasma after oral administration of raw and processed Atractylodis Rhizoma. Acetaminophen was used as the internal standard and the plasma samples were pretreated with methanol. Positive ionization mode coupled with multiple reaction monitoring mode was used to analyze the four compounds. The method validation revealed that all the calibration curves displayed good linear regression over the concentration ranges of 3.2–350, 4–500, 4–500, and 3.44–430 ng/mL for atractylenolides I, II, and III, and atractyloside A, respectively. The relative standard deviations of the intra- and inter-day precisions of the four compounds were less than 6% with accuracies (relative error) below 2.38%, and the extraction recoveries were more than 71.90 ± 4.97%. The main pharmacokinetic parameters of the four compounds were estimated with Drug and Statistics 3.0 and the integral pharmacokinetics were determined based on an area under the curve weighting method. The results showed that the integral maximum plasma concentration and area under the curve increased after oral administration of processed Atractylodis Rhizoma.
format Online
Article
Text
id pubmed-6320938
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-63209382019-01-14 UPLC-MS/MS of Atractylenolide I, Atractylenolide II, Atractylenolide III, and Atractyloside A in Rat Plasma after Oral Administration of Raw and Wheat Bran-Processed Atractylodis Rhizoma Xu, Shizhao Qi, Xiaojie Liu, Yuqiang Liu, Yuhan Lv, Xin Sun, Jianzhi Cai, Qian Molecules Article Atractylodis Rhizoma is the dried rhizome of Atractylodes lancea (Thunb.) DC. or Atractylodes chinensis (DC.) Koidz and is often processed by stir-frying with wheat bran to reduce its dryness and increase its spleen tonifying activity. However, the mechanism by which the processing has this effect remains unknown. To explain the mechanism based on the pharmacokinetics of the active compounds, a rapid, sensitive ultra-performance liquid chromatography-tandem mass spectrometry method was developed to analyze atractylenolides I, II, and III, and atractyloside A simultaneously in rat plasma after oral administration of raw and processed Atractylodis Rhizoma. Acetaminophen was used as the internal standard and the plasma samples were pretreated with methanol. Positive ionization mode coupled with multiple reaction monitoring mode was used to analyze the four compounds. The method validation revealed that all the calibration curves displayed good linear regression over the concentration ranges of 3.2–350, 4–500, 4–500, and 3.44–430 ng/mL for atractylenolides I, II, and III, and atractyloside A, respectively. The relative standard deviations of the intra- and inter-day precisions of the four compounds were less than 6% with accuracies (relative error) below 2.38%, and the extraction recoveries were more than 71.90 ± 4.97%. The main pharmacokinetic parameters of the four compounds were estimated with Drug and Statistics 3.0 and the integral pharmacokinetics were determined based on an area under the curve weighting method. The results showed that the integral maximum plasma concentration and area under the curve increased after oral administration of processed Atractylodis Rhizoma. MDPI 2018-12-07 /pmc/articles/PMC6320938/ /pubmed/30544552 http://dx.doi.org/10.3390/molecules23123234 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Xu, Shizhao
Qi, Xiaojie
Liu, Yuqiang
Liu, Yuhan
Lv, Xin
Sun, Jianzhi
Cai, Qian
UPLC-MS/MS of Atractylenolide I, Atractylenolide II, Atractylenolide III, and Atractyloside A in Rat Plasma after Oral Administration of Raw and Wheat Bran-Processed Atractylodis Rhizoma
title UPLC-MS/MS of Atractylenolide I, Atractylenolide II, Atractylenolide III, and Atractyloside A in Rat Plasma after Oral Administration of Raw and Wheat Bran-Processed Atractylodis Rhizoma
title_full UPLC-MS/MS of Atractylenolide I, Atractylenolide II, Atractylenolide III, and Atractyloside A in Rat Plasma after Oral Administration of Raw and Wheat Bran-Processed Atractylodis Rhizoma
title_fullStr UPLC-MS/MS of Atractylenolide I, Atractylenolide II, Atractylenolide III, and Atractyloside A in Rat Plasma after Oral Administration of Raw and Wheat Bran-Processed Atractylodis Rhizoma
title_full_unstemmed UPLC-MS/MS of Atractylenolide I, Atractylenolide II, Atractylenolide III, and Atractyloside A in Rat Plasma after Oral Administration of Raw and Wheat Bran-Processed Atractylodis Rhizoma
title_short UPLC-MS/MS of Atractylenolide I, Atractylenolide II, Atractylenolide III, and Atractyloside A in Rat Plasma after Oral Administration of Raw and Wheat Bran-Processed Atractylodis Rhizoma
title_sort uplc-ms/ms of atractylenolide i, atractylenolide ii, atractylenolide iii, and atractyloside a in rat plasma after oral administration of raw and wheat bran-processed atractylodis rhizoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320938/
https://www.ncbi.nlm.nih.gov/pubmed/30544552
http://dx.doi.org/10.3390/molecules23123234
work_keys_str_mv AT xushizhao uplcmsmsofatractylenolideiatractylenolideiiatractylenolideiiiandatractylosideainratplasmaafteroraladministrationofrawandwheatbranprocessedatractylodisrhizoma
AT qixiaojie uplcmsmsofatractylenolideiatractylenolideiiatractylenolideiiiandatractylosideainratplasmaafteroraladministrationofrawandwheatbranprocessedatractylodisrhizoma
AT liuyuqiang uplcmsmsofatractylenolideiatractylenolideiiatractylenolideiiiandatractylosideainratplasmaafteroraladministrationofrawandwheatbranprocessedatractylodisrhizoma
AT liuyuhan uplcmsmsofatractylenolideiatractylenolideiiatractylenolideiiiandatractylosideainratplasmaafteroraladministrationofrawandwheatbranprocessedatractylodisrhizoma
AT lvxin uplcmsmsofatractylenolideiatractylenolideiiatractylenolideiiiandatractylosideainratplasmaafteroraladministrationofrawandwheatbranprocessedatractylodisrhizoma
AT sunjianzhi uplcmsmsofatractylenolideiatractylenolideiiatractylenolideiiiandatractylosideainratplasmaafteroraladministrationofrawandwheatbranprocessedatractylodisrhizoma
AT caiqian uplcmsmsofatractylenolideiatractylenolideiiatractylenolideiiiandatractylosideainratplasmaafteroraladministrationofrawandwheatbranprocessedatractylodisrhizoma